Tyra Biosciences, Inc. (TYRA)

Tyra Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	91.97	58.01	251.21	302.18	15.22
Short-Term Investments	249.48	145.46	-	-	-
Cash & Short-Term Investments	341.44	203.47	251.21	302.18	15.22
Cash Growth	67.81%	-19.00%	-16.87%	1884.90%	13996.30%
Other Receivables	2	0.7	-	-	-
Receivables	2	0.7	-	-	-
Prepaid Expenses	4.02	7.5	6.08	1.88	0.06
Total Current Assets	347.46	211.67	257.29	304.06	15.28
Property, Plant & Equipment	7.72	8.15	3.54	2.09	0.47
Other Long-Term Assets	8.38	6.03	5.35	0.56	0.26
Total Assets	363.56	225.86	266.18	306.7	16.01
Accounts Payable	0.59	4.66	1.15	0.55	0.66
Accrued Expenses	13.59	10.39	4.42	2.86	1.05
Current Portion of Leases	0.41	0.28	0.14	0.2	0.14
Total Current Liabilities	14.59	15.33	5.7	3.62	1.86
Long-Term Leases	5.81	6.22	2.48	0.98	-
Other Long-Term Liabilities	0	0.05	0.17	0.37	0.14
Total Liabilities	20.41	21.6	8.35	4.96	2
Common Stock	0.01	0	0	0	-
Additional Paid-In Capital	593.69	368.71	353.52	342.1	0.44
Retained Earnings	-251.31	-164.83	-95.7	-40.37	-14.08
Comprehensive Income & Other	0.77	0.38	-	-	-
Total Common Equity	343.15	204.26	257.83	301.74	-13.64
Shareholders' Equity	343.15	204.26	257.83	301.74	14.01
Total Liabilities & Equity	363.56	225.86	266.18	306.7	16.01
Total Debt	6.22	6.5	2.62	1.18	0.14
Net Cash (Debt)	335.22	196.97	248.59	301	15.08
Net Cash Growth	70.19%	-20.76%	-17.41%	1895.75%	-
Net Cash Per Share	5.86	4.61	5.94	21.84	9.78
Filing Date Shares Outstanding	53.09	52.52	42.43	41.11	1.83
Total Common Shares Outstanding	50.75	43.02	42.35	40.95	1.83
Working Capital	332.87	196.34	251.59	300.44	13.42
Book Value Per Share	6.76	4.75	6.09	7.37	-7.45
Tangible Book Value	343.15	204.26	257.83	301.74	-13.64
Tangible Book Value Per Share	6.76	4.75	6.09	7.37	-7.45
Machinery	2.46	2.03	1.38	1.06	0.34
Leasehold Improvements	0.47	0.4	0.16	0.14	-

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q